소화관 스텐트 시장 규모, 점유율, 성장 분석 : 제품별, 재질별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Gastrointestinal Stents Market size was valued at USD 5.29 Billion in 2024 and is poised to grow from USD 5.58 Billion in 2025 to USD 8.56 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The gastrointestinal stents market is witnessing consistent growth, fueled by the rising incidence of gastrointestinal disorders and an expanding elderly population. Factors such as lifestyle changes, unhealthy diets, and increasing obesity rates have led to more cases of conditions like colorectal cancer and inflammatory bowel disease. This surge in gastrointestinal issues has increased the demand for stents, known for their effective and minimally invasive treatments that enhance patients' quality of life. As the elderly population grows, age-related gastrointestinal ailments such as strictures and diverticulitis are becoming more common, further driving demand. Innovations like self-expandable metal stents and biodegradable options are transforming treatment outcomes, while new designs with anti-migration features enhance long-term effectiveness and patient comfort in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gastrointestinal Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gastrointestinal Stents Market Segments Analysis

Global Gastrointestinal Stents Market is segmented by products, material, application, end users and region. Based on products, the market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents and esophageal stents. Based on material, the market is segmented into self-expanding metal stents, nitinol, plastic stents and others. Based on application, the market is segmented into biliary diseases, irritable bowel syndrome, gastrointestinal cancers, colorectal cancer, stomach cancer, esophageal cancer and pancreatic cancer. Based on end users, the market is segmented into hospitals and clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Gastrointestinal Stents Market

The increasing awareness of the advantages of gastrointestinal stents among both patients and healthcare professionals has contributed to early detection and prompt treatment of gastrointestinal issues. Additionally, enhanced accessibility to healthcare services in emerging regions has led to a surge in the utilization of stenting procedures. This growing recognition, coupled with improved healthcare infrastructure, has significantly fueled the expansion of the gastrointestinal stents market, as more individuals seek effective solutions for their conditions, thereby driving demand for these innovative medical devices. The combination of education and access is playing a crucial role in transforming treatment approaches in this field.

Restraints in the Gastrointestinal Stents Market

Certain areas experience restrictions in reimbursement policies related to gastrointestinal stent procedures, which may impose rigorous requirements. This limitation can adversely affect the affordability and accessibility of stent-based treatment options. As a result, patients facing financial constraints may be deterred from seeking these medical interventions, ultimately stymying market expansion. When reimbursement is inadequate or difficult to navigate, healthcare providers might hesitate to recommend or utilize these devices, leading to a decrease in overall demand. Consequently, these constraints can present significant challenges for the growth and development of the gastrointestinal stents market, affecting both providers and patients alike.

Market Trends of the Gastrointestinal Stents Market

The gastrointestinal stents market is witnessing a notable shift towards biodegradable options, reflecting a growing preference among healthcare providers and patients for innovative solutions that enhance treatment outcomes. Biodegradable stents present clear benefits over traditional metallic alternatives, primarily by eliminating the need for cumbersome removal procedures while simultaneously minimizing complications related to permanent implants. As these stents are designed to dissolve gradually, they support affected areas effectively during the healing process, allowing for natural tissue regeneration. This trend underscores a broader movement towards patient-centric medical devices that prioritize safety, convenience, and improved overall care in gastrointestinal treatments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Gastrointestinal Stents Market Size by Products & CAGR (2026-2033)

• Market Overview
• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

Global Gastrointestinal Stents Market Size by Material & CAGR (2026-2033)

• Market Overview
• Self-Expanding Metal Stents
• Nitinol
• Plastic Stents
• Others

Global Gastrointestinal Stents Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers
• Colorectal Cancer
• Stomach Cancer
• Esophageal Cancer
• Pancreatic Cancer

Global Gastrointestinal Stents Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals And Clinics
• Ambulatory Surgical Centers

Global Gastrointestinal Stents Market Size & CAGR (2026-2033)

• North America (Products, Material, Application, End Users)
  • USA
  • Canada
• Europe (Products, Material, Application, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Products, Material, Application, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Products, Material, Application, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products, Material, Application, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELLA-CS s.r.o. (Czech Republic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hobbs Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taewoong Medical Co. Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S&G Biotech Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations